Sirolimus (Rapamycin) 2mg, 10 Tablets — TM SiroBoon

SiroBoon 2 (Sirolimus / Rapamycin) — 10 Tablets (1 Blister)

SiroBoon 2 is a high-quality sirolimus (rapamycin) formulation produced by the reputable Indian manufacturer Kachhela Medex. This product listing offers a single blister pack containing 10 tablets, providing an ideal and precise quantity for customized anti-aging and longevity protocols.

General Pharmaceutical & Manufacturer Information

• Brand Name: SiroBoon 2
• Active Ingredient: Sirolimus (historically known as Rapamycin)
• Dosage: 2 mg of Sirolimus per tablet
• Package Size: 1 Blister (10 tablets)
• CAS Number: 53123-88-9
• Molecular Formula: C51H79NO13
• Pharmacological Class: Selective Mechanistic Target of Rapamycin (mTOR) inhibitor
• Manufacturer: Kachhela Medex Pvt. Ltd., India
• Manufacturer Profile: Founded in 2004, Kachhela Medex is an established, ISO 9001:2008 and WHO-GMP certified pharmaceutical company. They are globally recognized for manufacturing and exporting high-quality generic medications and life-saving drugs that strictly adhere to international safety standards, making SiroBoon 2 a trusted choice worldwide.

Anti-Aging & Longevity Properties (Geroprotection)

In modern longevity medicine, sirolimus (rapamycin) is recognized as one of the most thoroughly researched and promising geroprotectors. Rather than merely masking the superficial signs of aging, it targets the fundamental cellular mechanisms driven by the aging process.

1. mTORC1 Pathway Inhibition

The mTOR complex regulates cell growth and metabolism. Over time, its chronic hyperactivation leads to the accumulation of cellular waste and accelerated tissue aging. SiroBoon 2 downregulates overactive mTORC1 signaling, mimicking the biological benefits of caloric restriction to slow down the pace of biological aging.

2. Activation of Autophagy

By inhibiting the mTOR pathway, the drug triggers autophagy—the cell's natural "recycling" system. This process clears out damaged proteins, dysfunctional mitochondria, and toxic metabolic debris, effectively rejuvenating tissues at a cellular level.

3. Reduction of Systemic Inflammation (SASP)

Rapamycin effectively suppresses the Senescence-Associated Secretory Phenotype (SASP). It reduces the production of pro-inflammatory cytokines by senescent ("zombie") cells, thereby mitigating inflammaging—the chronic, low-grade inflammation that underlies most age-related diseases.

4. Metabolic and Cognitive Preservation

In longevity regimens, sirolimus is utilized to help optimize insulin sensitivity, support cardiovascular health against age-related arterial stiffness, and maintain neuroplasticity to protect the brain from cognitive decline.

Administration in Longevity Protocols

Unlike its high-dose daily use in transplantation medicine, anti-aging protocols typically employ rapamycin in intermittent, low-dose schedules (e.g., 2 mg to 6 mg taken once weekly). This pulse-dosing strategy is designed to maximize geroprotective benefits while avoiding chronic immune suppression and minimizing potential side effects.

Disclaimer: The use of sirolimus for longevity purposes should always be conducted under the supervision of a qualified anti-aging specialist or physician, alongside regular blood work panels (including lipid profiles, glucose levels, and complete blood counts).